BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8037747)

  • 1. A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption.
    Hall TJ
    Biochem Biophys Res Commun; 1994 Jul; 202(1):456-62. PubMed ID: 8037747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bone-specific estrogen centchroman inhibits osteoclastic bone resorption in vitro.
    Hall TJ; Nyugen H; Schaueblin M; Fournier B
    Biochem Biophys Res Commun; 1995 Nov; 216(2):662-8. PubMed ID: 7488162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of reactive oxygen intermediates in osteoclastic bone resorption.
    Hall TJ; Schaeublin M; Jeker H; Fuller K; Chambers TJ
    Biochem Biophys Res Commun; 1995 Feb; 207(1):280-7. PubMed ID: 7857277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
    Kameda T; Miyazawa K; Mori Y; Yuasa T; Shiokawa M; Nakamaru Y; Mano H; Hakeda Y; Kameda A; Kumegawa M
    Biochem Biophys Res Commun; 1996 Mar; 220(3):515-9. PubMed ID: 8607797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor".
    Zaidi M; Kerby J; Huang CL; Alam T; Rathod H; Chambers TJ; Moonga BS
    J Cell Physiol; 1991 Dec; 149(3):422-7. PubMed ID: 1660481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro.
    Hall TJ; Schaeublin M; Chambers TJ
    Biochem Biophys Res Commun; 1993 Sep; 195(3):1245-53. PubMed ID: 8216256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that c-src is involved in the process of osteoclastic bone resorption.
    Hall TJ; Schaeublin M; Missbach M
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1237-44. PubMed ID: 8147865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
    Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
    J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High extracellular calcium concentrations directly stimulate osteoclast apoptosis.
    Lorget F; Kamel S; Mentaverri R; Wattel A; Naassila M; Maamer M; Brazier M
    Biochem Biophys Res Commun; 2000 Feb; 268(3):899-903. PubMed ID: 10679302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts.
    Kajiya H; Okabe K; Okamoto F; Tsuzuki T; Soeda H
    J Cell Physiol; 2000 Apr; 183(1):83-90. PubMed ID: 10699969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
    Sugawara K; Hamada M; Hosoi S; Tamaoki T
    Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
    Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
    J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of pHi in osteoclasts is dependent on the culture substrate and on the stage of the resorption cycle.
    Lehenkari PP; Laitala-Leinonen T; Linna TJ; Väänänen HK
    Biochem Biophys Res Commun; 1997 Jun; 235(3):838-44. PubMed ID: 9207248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor induces pseudopod formation in calcitonin-treated rabbit osteoclasts.
    Gravel MR; Zheng ZG; Sims SM; Dixon SJ
    J Bone Miner Res; 1994 Nov; 9(11):1769-76. PubMed ID: 7863828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclasts are capable of particle phagocytosis and bone resorption.
    Wang W; Ferguson DJ; Quinn JM; Simpson AH; Athanasou NA
    J Pathol; 1997 May; 182(1):92-8. PubMed ID: 9227347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gamma-glutamyl peptide isolated from onion (Allium cepa L.) by bioassay-guided fractionation inhibits resorption activity of osteoclasts.
    Wetli HA; Brenneisen R; Tschudi I; Langos M; Bigler P; Sprang T; Schürch S; Mühlbauer RC
    J Agric Food Chem; 2005 May; 53(9):3408-14. PubMed ID: 15853380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1.
    Chambers TJ; Ali NN
    J Pathol; 1983 Mar; 139(3):383-97. PubMed ID: 6339702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.